Provider of enterprise-grade messaging services. The company offers a secure mobile messaging platform and mobile application that provides mobile and Web-based secure messaging and allows enterprises, hospitals and physician groups to create their own private mobile messaging network for physicians, nurses and administrators.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
10/08/2020 | Series D-2 | $3.6MM | $xx.xx | $366.32MM | Healthquest Capital, Industry Ventures, Invus, Montreux Growth Partners, New Leaf Ventures, Norwest Venture Partners | |
Price per Share
$xx.xx
Shares Outstanding
2,737,831
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
20.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Healthquest Capital, Industry Ventures, Invus, Montreux Growth Partners, New Leaf Ventures, Norwest Venture Partners
|
||||||
10/08/2020 | Series D-1 | $41.5MM | $xx.xx | $366.32MM | Healthquest Capital, Industry Ventures, Invus, Montreux Growth Partners, New Leaf Ventures, Norwest Venture Partners | |
Price per Share
$xx.xx
Shares Outstanding
9,880,398
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Healthquest Capital, Industry Ventures, Invus, Montreux Growth Partners, New Leaf Ventures, Norwest Venture Partners
|
||||||
11/12/2015 | Series C-1 | $12.93MM | $xx.xx | $188.83MM | Accolade Partners, Invus Group, Norwest Venture Partners, Orbimed, Reed Elsevier, Shasta Ventures | |
Price per Share
$xx.xx
Shares Outstanding
5,213,388
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Accolade Partners, Invus Group, Norwest Venture Partners, Orbimed, Reed Elsevier, Shasta Ventures
|
||||||
11/12/2015 | Series C | $33.31MM | $xx.xx | $188.83MM | Accolade Partners, Invus Group, Norwest Venture Partners, Orbimed, Reed Elsevier, Shasta Ventures | |
Price per Share
$xx.xx
Shares Outstanding
14,243,885
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Accolade Partners, Invus Group, Norwest Venture Partners, Orbimed, Reed Elsevier, Shasta Ventures
|
||||||
01/27/2014 | Series B | $23.42MM | $xx.xx | $61.79MM | Easton Capital, New Leaf Venture Partners, New Science Ventures, Orbimed, Reed Elsevier Ventures, Shasta Ventures, Telus Corporation | |
Price per Share
$xx.xx
Shares Outstanding
17,512,573
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Easton Capital, New Leaf Venture Partners, New Science Ventures, Orbimed, Reed Elsevier Ventures, Shasta Ventures, Telus Corporation
|
||||||
03/14/2013 | Series A | $11.62MM | $xx.xx | $21.13MM | Easton Capital, New Science Ventures | |
Price per Share
$xx.xx
Shares Outstanding
10,590,275
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Easton Capital, New Science Ventures
|
||||||
09/28/2010 | Series Seed | $1.55MM | $xx.xx | $5.15MM | Akamai Randall Kaplan, Herb Madan | |
Price per Share
$xx.xx
Shares Outstanding
1,931,250
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Akamai Randall Kaplan, Herb Madan
|